Novo Nordisk aims to launch more than 5 blockbuster drugs

RTE 1 min read 2 hours ago

Novo Nordisk aims to launch more than five blockbuster drugs by 2030 and to deliver more than 150 billion Danish crowns ($23 billion) in pipeline sales in 2035, its CEO Mike Doustdar said at its Capital Markets Day in London.